Type 2 diabetes
Type 2 diabetes is a chronic metabolic condition in which blood glucose rises because the body does not use insulin effectively and, over time, may not make enough insulin. This page combines clinical reference content with terminology, diagnostic pathways, treatment relationships and geographic data.
At a glance
Quick facts
- Condition type
- Chronic metabolic disease
- Main systems affected
- Pancreas & metabolism · blood vessels · kidneys · eyes · nerves
- Contagious
- No
- Course / curability
- Chronic · manageable · remission is possible for some people
- Typical onset
- Can occur at any age; commonly diagnosed in adulthood
- Global burden
- 589 million adults live with diabetes overall [6] Age 20–79 · 2024 · IDF
Dr. Augustine Chinemerem Anadu
Consultant Family Physician · University of Calabar Teaching Hospital
Reviewed for clinical accuracy, practical wording and general-medicine context.
Names & terminology
How type 2 diabetes may be named or searched
- Canonical name
- Type 2 diabetes
- Medical name
- Type 2 diabetes mellitus
- Abbreviations
- T2DM · T2D · type 2 DM
- Search / word-order variants
- Type II diabetes · diabetes mellitus type 2 · diabetes type 2 · T2 diabetes
- Historical terminology
- Non-insulin-dependent diabetes mellitus (NIDDM) · non-insulin-dependent diabetes · adult-onset diabetes — retained for search and historical understanding, not presented as preferred current terminology
Not every query variant is an exact medical synonym. The search index can recognize useful variants while the visible page labels historical, colloquial and word-order forms separately.
Structured entity profile
Clinical profile
Overview
Type 2 diabetes is the most common form of diabetes. It develops when the body does not use insulin effectively and, over time, may also fail to make enough insulin to keep blood glucose in a healthy range. Symptoms can develop slowly, and some people have no noticeable symptoms when the condition is first detected. [2] [4]
Signs and symptoms
Possible symptoms include increased thirst and urination, increased hunger, tiredness, blurred vision, numbness or tingling in the hands or feet, sores that heal slowly and unexplained weight loss. Type 2 diabetes may remain asymptomatic for years, so symptoms alone cannot confirm or exclude it. [2]
SYMPTOM MATRIX
How symptoms may present
Symptoms alone cannot diagnose or exclude type 2 diabetes.
- Increased thirst
- Frequent urination
- Increased hunger
- Fatigue
- Blurred vision
- Slow-healing sores
- Recurrent infections
- Tingling or numbness
- Unexplained weight loss
- No noticeable symptoms
- Severe dehydration
- Persistent vomiting
- Marked drowsiness or confusion
- Breathing difficulty
- Suspected hyperglycaemic crisis
Red flags are not a self-diagnosis tool; urgent symptoms need clinical assessment.
Diagnosis
Diabetes can be diagnosed using A1C or plasma-glucose criteria, including fasting plasma glucose, a 2-hour glucose value during a 75-g oral glucose tolerance test, or—in someone with classic symptoms or a hyperglycemic crisis—a random plasma glucose result. In the absence of unequivocal hyperglycemia, current ADA guidance requires confirmatory testing. [1] [3]
I pay particular attention to family history during assessment because type 2 diabetes has a strong genetic component. Family history does not make the diagnosis by itself, but it meaningfully changes the clinical context and the patient’s risk profile.
Diagnostic pathway
How type 2 diabetes is diagnosed
A simplified patient-facing flow based on laboratory diagnosis guidance.
Diagnostic thresholds shown from NIDDK / ADA-based guidance. Source [3]
Treatment and ongoing care
Management is individualized and can include nutrition and physical-activity changes, weight management, glucose-lowering medicines and ongoing monitoring for cardiovascular, kidney, eye, nerve and other complications. Choice of medicine increasingly depends on the person’s cardiovascular and kidney disease, weight goals, hypoglycaemia risk and other clinical factors rather than on a single universal sequence. [5]
The goal is not simply to lower a laboratory number. I work with patients to set an individualized glycaemic target and make sure they have the education, support and treatment resources needed to reach it safely. I also emphasize hypoglycaemia when treatment can cause it, because patients need to know the warning signs, how to prevent it and when to seek help.
Metformin remains a common starting medicine in my practice, but treatment should be individualized. Kidney function is one of the checks I pay close attention to; metformin should be stopped if eGFR falls below 30 mL/min/1.73 m², and cardiovascular, kidney and weight-related factors may change the preferred treatment choice.
Treatment & INN hub
Medicines are selected by clinical context
The medicine graph connects treatment classes to individual INN pages rather than ranking one drug as universally “best”.
Metformin →
Core glucose-lowering medicine. NICE 2026 uses modified-release metformin in multiple initial-treatment pathways.
Empagliflozin · Dapagliflozin
Used in current pathways according to cardiovascular, kidney, obesity and frailty context.
Semaglutide · Dulaglutide · Tirzepatide
Considered in particular treatment pathways depending on comorbidities, glycaemic goals and suitability.
DPP-4 inhibitors · Sulfonylureas · Pioglitazone · Insulin
Choice depends on response, contraindications, renal status, hypoglycaemia risk and treatment goals.
Treatment examples summarize current NICE NG28 medicine pathways; they are not an individualized prescription. Source [5]
Possible complications
Over time, diabetes can damage blood vessels and nerves and increase the risk of heart disease, stroke, kidney disease, vision loss and foot problems. Risk varies between individuals and can be reduced through appropriate glucose management and control of other cardiovascular and kidney risk factors. [2]
Foot care deserves to be discussed on its own. I routinely educate patients about preventive foot care because ulcers and other foot complications can progress to infection and, in severe cases, amputation.
Geo data · IDF Diabetes Atlas 2025
Diabetes around the world
One canonical condition page, with a comparable country layer. Swipe or scroll the country strip when more markets are available.
Common questions
Frequently asked questions
Type 2 diabetes is a chronic condition in which blood glucose is too high because the body does not use insulin effectively and may not make enough insulin over time.
Symptoms can include increased thirst and urination, hunger, tiredness, blurred vision, tingling or numbness, slow-healing sores and unexplained weight loss. Some people have no noticeable symptoms.
Diagnosis uses laboratory A1C or plasma-glucose tests. In the absence of unequivocal hyperglycemia, abnormal results generally need confirmation.
Treatment is individualized and can include nutrition and physical activity, weight management, medicines and regular monitoring. Medicine choice depends on the person’s overall cardiovascular, kidney and metabolic profile.
Yes. Over time it can increase the risk of cardiovascular disease, kidney disease, eye disease, nerve damage and foot problems, although good ongoing management can reduce risk.
Sources
Clinical statements in this reference are linked to current guideline, government and public-health sources. The
- 1. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. ADA Standards ↗
- 2. NIDDK. Type 2 Diabetes — overview, symptoms, causes, diagnosis and management. NIDDK reference ↗
- 3. NIDDK. Diabetes Tests & Diagnosis. Diagnosis reference ↗
- 4. CDC. About Type 2 Diabetes, reviewed May 2024. CDC reference ↗
- 5. NICE. Type 2 diabetes in adults: management (NG28), updated 18 February 2026. NICE guideline ↗
- 6. International Diabetes Federation. IDF Diabetes Atlas, 11th edition (2025): global and country estimates for 2024 and projections to 2050. IDF Atlas ↗
- 7. World Health Organization. International Classification of Diseases: ICD-10 E11 and ICD-11 5A11 classification resources. WHO ICD ↗
- 8. Diabetes UK. Type 2 diabetes remission: remission is possible for some people but is not considered a cure. Remission reference ↗
This article is based on trusted medical sources and has been reviewed by a clinician. It is not a substitute for personalized medical advice.
When assessing patients, I pay particular attention to recurrent superficial infections and slow wound healing because they can be clues that glycaemic control is poor. Unexplained weight loss also deserves extra attention, especially in a younger adult or atypical presentation where significant insulin deficiency or another diabetes phenotype may have been missed.
When I see unexplained weight loss, especially in a younger adult, I go back carefully through the timing of symptoms and reconsider the diabetes type. I have seen patients initially labelled as type 2 diabetes whose presentation needed reassessment for significant insulin deficiency.